Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2018 / Article

Retraction | Open Access

Volume 2018 |Article ID 9686012 | https://doi.org/10.1155/2018/9686012

Evidence-Based Complementary and Alternative Medicine, "Retracted: Antioxidant Activity and Characterization of One New Polysaccharide Obtained from Perigord Truffle (Tuber huidongense)", Evidence-Based Complementary and Alternative Medicine, vol. 2018, Article ID 9686012, 1 page, 2018. https://doi.org/10.1155/2018/9686012

Retracted: Antioxidant Activity and Characterization of One New Polysaccharide Obtained from Perigord Truffle (Tuber huidongense)

Received28 Nov 2017
Accepted28 Nov 2017
Published14 Jan 2018

Evidence-Based Complementary and Alternative Medicine has retracted the article titled “Antioxidant Activity and Characterization of One New Polysaccharide Obtained from Perigord Truffle (Tuber huidongense)” [1] at the request of the authors. The first author says the HPLC and NMR results are not reproducible, while the fourth author did not approve the article’s submission and disputes the authorship.

References

  1. Y.-F. Chen, W.-W. Jiang, S.-Q. Zhang, J.-Q. Kan, and Y. Liang, “Antioxidant Activity and Characterization of One New Polysaccharide Obtained from Perigord Truffle (Tuber huidongense),” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 3537193, 7 pages, 2016. View at: Publisher Site | Google Scholar

Copyright © 2018 Evidence-Based Complementary and Alternative Medicine. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views635
Downloads293
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.